Seeing Is Believing
TMBR is currently covered by 1 analysts with an average price target of $-0.5. This is a potential upside of $-0.5 (0%) from yesterday's end of day stock price of $0.
Timber Pharmaceuticals's activity chart (see below) currently has 0 price targets and 4 ratings on display. The stock rating distribution of TMBR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 225 days.
Highest price target for TMBR is $12, Lowest price target is $6, average price target is $-0.5.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 28-Aug-2023. First documented stock forecast 02-May-2022.
Currently out of the existing stock ratings of TMBR, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1
7 months 29 days ago
1/1 (100%)
$-0.5 (-33.33%)
225
What is TMBR (Timber Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on TMBR (Timber Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on TMBR (Timber Pharmaceuticals)?
Which analyst is the currently most bullish on TMBR (Timber Pharmaceuticals)?